Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00411463 · ClinicalTrials.gov registry record · Phase 2
Psychotherapy for Bipolar II Depression, Pilot Study, Phase II
A Phase 2 study of Bipolar II Disorder, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 2
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT00411463 is a Phase 2 study of Bipolar II Disorder that has completed, run by University of Pittsburgh. The registered enrollment target is 25 participants, below the 86-participant average among 13 other Bipolar II Disorder trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00411463, a Phase 2 study of Bipolar II Disorder, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Purpose of this study is to examine the effectiveness of an experimental psychotherapy (talk therapy) for the treatment of bipolar II depression. The name of this psychotherapy is Interpersonal and Social Rhythm Therapy for Bipolar II Depression (IPSRT-BPII). Subjects will be randomly assigned to receive either IPSRT-BPII or the medication Seroquel (quetiapine) to manage their symptoms of bipolar II depression. Subjects will receive the assigned therapy for up to 20 weeks.
Conditions Studied
Interventions
- BEHAVIORAL Interpersonal and Social Rhythm Therapy (IPSRT-BPII)
- DRUG Seroquel
Study Locations (1)
Pennsylvania
- University of Pittsburgh /University of Pittsburgh Medical Center (UPMC) - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2006-12 |
| Est. Completion | 2010-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00411463
The ClinicalTrials.gov registry entry for NCT00411463 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 86-participant average among 13 other Bipolar II Disorder trials with a reported enrollment target (71% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bipolar II Disorder appearing as the primary indexed condition, and to 2 interventions - of which Interpersonal and Social Rhythm Therapy (IPSRT-BPII) is the first listed.
NCT00411463 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00411463 about?
NCT00411463 is a clinical study titled "Psychotherapy for Bipolar II Depression, Pilot Study, Phase II". Purpose of this study is to examine the effectiveness of an experimental psychotherapy (talk therapy) for the treatment of bipolar II depression. The name of this psychotherapy is Interpersonal and Social Rhythm Therapy for Bipolar II Depression (IPSRT-BPII). Subjects will be randomly assigned to re...
What is the current status of trial NCT00411463?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 25 participants. The study started on 2006-12. Estimated completion is 2010-09.
What conditions does trial NCT00411463 study?
This clinical trial studies the following conditions: Bipolar II Disorder.
What interventions are being tested in trial NCT00411463?
The interventions under investigation include: Interpersonal and Social Rhythm Therapy (IPSRT-BPII) (BEHAVIORAL), Seroquel (DRUG).
Who is sponsoring clinical trial NCT00411463?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00411463 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar II Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders
RECRUITING · Phase 2
-
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
RECRUITING · Phase 2
-
Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality
RECRUITING · Phase 2
-
Psilocybin Therapy for Depression in Bipolar II Disorder
ACTIVE NOT RECRUITING · Phase 2
-
Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder
ACTIVE NOT RECRUITING · Phase 2
-
Treating Smokers With Mental Illness
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.